Chirality Biosciences: Funding, Investors & Team (Sep 2026)
Chirality Biosciences is a developer of chiral molecule separation technology enabling faster, safer, and side-effect-free drug production.
Chirality Biosciences has raised $3.1M across 1 funding round on record, the most recent a Pre-Seed of $3.1M announced in Oct 2025.
That round is below the $21M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Chirality Biosciences Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Chirality Biosciences Funding Rounds
Chirality Biosciences Founders and Leadership Team
Contact details for the Chirality Biosciences team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Chirality Biosciences Funding Compared to Other Biotechnology Startups
Chirality Biosciences' latest round of $3.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Chirality Biosciences in Biotechnology and Farmingdale
Companies Similar to Chirality Biosciences
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other…
Ollin Biosciences operates as a clinical-stage biopharmaceutical company.
Dayra Therapeutics manufactures peptide based medicines.
Bexorg provides a technology platform for central nervous system drug discovery and development.
AeroRx Therapeutics is a biopharmaceutical company that developing proprietary, combination products.
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for…
Oligon is an emerging biotechnology company developing a novel class of multimodal RNA therapeutics.
AltrixBio is a pharmaceutical company focused on oral drug that replicates the metabolic success of bariatric…
SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune…
Enlaza Therapeutics is a biotechnology research company.
4TEEN4 Pharmaceuticals develops innovative therapies and biomarkers for diagnosis, prediction, and treatment…
Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and…
Chirality Biosciences Funding FAQs
What does Chirality Biosciences do?
Chirality Biosciences is a developer of chiral molecule separation technology enabling faster, safer, and side-effect-free drug production.
How much funding has Chirality Biosciences raised?
Chirality Biosciences has raised $3.1M across 1 round on record. The most recent is a Pre-Seed of $3.1M announced in Oct 2025.
When did Chirality Biosciences last raise funding?
Chirality Biosciences' most recent funding round on record is a Pre-Seed of $3.1M, announced in Oct 2025.
Who is the CEO of Chirality Biosciences?
Arielle Gabalski is listed as CEO at Chirality Biosciences.
Where is Chirality Biosciences headquartered?
Chirality Biosciences is based in Farmingdale, United States.
How many employees does Chirality Biosciences have?
Chirality Biosciences is in the 1-10 employee band.
How does Chirality Biosciences' funding compare to other Biotechnology startups?
Chirality Biosciences' latest round of $3.1M is below the $21M median round size for Biotechnology companies on FundedIQ across 29 tracked companies over the last two years.
About FundedIQ's Chirality Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Chirality Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.